Eli Lilly and Company (LLY) Income Statement: Revenue & Earnings

Eli Lilly and Company Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

Eli Lilly and Company income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	65.18	45.04	34.12	28.54	28.32	24.54	22.32	21.49	19.97
Cost of Revenue	11.05	8.42	7.08	6.63	7.31	5.48	4.72	4.68	4.45
Gross Profit	54.13	36.62	27.04	21.91	21.35	19.06	17.60	16.81	15.53
Operating Expenses
Research & Development	16.25	10.99	9.31	7.19	7.90	5.98	5.60	5.05	5.10
Selling, General & Administrative	11.09	8.13	7.40	6.44	6.43	5.87	6.00	5.73	6.18
Operating Expenses	24.43	19.12	16.72	13.63	13.07	11.85	11.60	10.79	11.28
Operating Income	29.70	17.50	10.33	8.28	8.27	7.21	6.00	6.03	4.25
Other Income/Expense
Interest Income	0.15	0.18	0.17	0.06	0.03	0.03	0.08	0.16	0.17
Interest Expense	0.80	0.78	0.49	0.33	-0.34	0.36	0.40	0.24	0.23
Other Income/Expense	-0.57	-4.82	-3.77	-1.21	0.26	0.02	-0.73	-2.35	-1.95
Income
Income Before Tax	25.73	12.68	6.55	6.81	6.16	7.23	5.27	3.68	2.30
Income Tax Expense	5.09	2.09	1.31	0.56	0.57	1.04	0.63	0.53	2.39
Net Income	20.64	10.59	5.24	6.24	5.58	6.19	8.32	3.23	-0.20
Net Income - Continuous Operations	20.64	10.59	5.24	6.24	5.58	6.19	8.32	3.23	-0.20
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	28.30	15.23	11.85	8.66	7.90	8.91	6.90	5.53	4.10
EBIT	26.30	12.90	10.33	7.14	6.36	0.00	0.00	0.00	0.00
Depreciation & Amortization	2.00	1.77	1.53	1.52	1.55	1.32	1.23	1.61	1.57
Earnings Per Share
Basic EPS	23.00	12.00	6.00	7.00	6.00	6.00	9.00	3.00	-
Diluted EPS	23.00	12.00	6.00	7.00	6.00	6.00	9.00	3.00	-
Basic Shares Outstanding	0.90	0.90	0.90	0.95	0.91	0.96	0.96	1.03	1.05
Diluted Shares Outstanding	0.90	0.90	0.90	0.95	0.91	0.96	0.96	1.03	1.05